1 Min Read
Oct 6 (Reuters) - PanOptica:
* PanOptica - secures $11 million to advance clinical development of PAN-90806 - a novel, topical anti-VEGF eye drop Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.